Abstract
UDP-glucuronosyltransferase (UDP) catalyzes a broad spectrum of endobiotic and xenobiotics. It is the isoform of the UGT1 family, which are made from the complex gene locus by an alternative combination of one of the unique first exons with the commonly used exons. UDP is believed to be involved in cellular activity and signaling process associated with detoxification. In this study, rats were orally administered with 18β-glycyrrhetinic acid (GA) for four weeks before rats were sacrificed. The mRNA was extracted from the liver and cDNA was prepared by reverse transcription method. By PCR and Northern blot analysis, UGT1A8 mRNA level was found to be increased in the treatment group (P < 0.05). The results showed that the mRNA expression of UGT1A8 could be induced both by GA and the licorice extract. GA was identified to be the active component of the aqueous extract of licorice responsible for induction of UGT1A8 in the rat liver. The results suggest a transcriptional control of the UGT1A8 synthesis can be modulated by phytochemicals in the rat liver. The increased UDP activity could enhance detoxification of toxicants.
Keywords: UGT1A8, induction, transcription, expression, 18β-glycyrrhetinic acid.
Protein & Peptide Letters
Title:18β-glycyrrhetinic Acid Induces UDP-glucuronosyltransferase in Rats
Volume: 20 Issue: 12
Author(s): Kai Woo Lee and Wing Shing Ho
Affiliation:
Keywords: UGT1A8, induction, transcription, expression, 18β-glycyrrhetinic acid.
Abstract: UDP-glucuronosyltransferase (UDP) catalyzes a broad spectrum of endobiotic and xenobiotics. It is the isoform of the UGT1 family, which are made from the complex gene locus by an alternative combination of one of the unique first exons with the commonly used exons. UDP is believed to be involved in cellular activity and signaling process associated with detoxification. In this study, rats were orally administered with 18β-glycyrrhetinic acid (GA) for four weeks before rats were sacrificed. The mRNA was extracted from the liver and cDNA was prepared by reverse transcription method. By PCR and Northern blot analysis, UGT1A8 mRNA level was found to be increased in the treatment group (P < 0.05). The results showed that the mRNA expression of UGT1A8 could be induced both by GA and the licorice extract. GA was identified to be the active component of the aqueous extract of licorice responsible for induction of UGT1A8 in the rat liver. The results suggest a transcriptional control of the UGT1A8 synthesis can be modulated by phytochemicals in the rat liver. The increased UDP activity could enhance detoxification of toxicants.
Export Options
About this article
Cite this article as:
Lee Woo Kai and Ho Shing Wing, 18β-glycyrrhetinic Acid Induces UDP-glucuronosyltransferase in Rats, Protein & Peptide Letters 2013; 20 (12) . https://dx.doi.org/10.2174/092986652012131112124033
DOI https://dx.doi.org/10.2174/092986652012131112124033 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
p53: Fighting Cancer
Current Cancer Drug Targets Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?
Current Vascular Pharmacology The Effects of Statin Therapy on the Human Airway
Drug Metabolism Letters Advances in Photodynamic Therapy of Cancer
Current Cancer Therapy Reviews Tissue Elasticity Bridges Cancer Stem Cells to the Tumor Microenvironment Through microRNAs: Implications for a “Watch-and-Wait” Approach to Cancer
Current Stem Cell Research & Therapy Synthesis of Novel Test Compounds for Antiviral Chemotherapy of Severe Acute Respiratory Syndrome (SARS)
Current Medicinal Chemistry Proteinases as Biomarkers in Breast Cancer Prognosis and Diagnosis
Mini-Reviews in Medicinal Chemistry Antidiabetic Effect of Polyphenolic Extracts from Selected Edible Plants as α-Amylase, α -Glucosidase and PTP1B Inhibitors, and β Pancreatic Cells Cytoprotective Agents - A Comparative Study
Current Topics in Medicinal Chemistry Synthesis and Biological Evaluation of New Pyrazole-based Thiazolyl Hydrazone Derivatives as Potential Anticancer Agents
Letters in Drug Design & Discovery Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses
Current Cancer Drug Targets Gene Therapy Approaches to Ataxias
Current Gene Therapy Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Current Cancer Drug Targets Actively Targeted Nanoparticles for Drug Delivery to Tumor
Current Drug Metabolism MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews Targeting Tumor Lymphangiogenesis: An Update
Current Medicinal Chemistry Targeting Mitochondria: A New Promising Approach for the Treatment of Liver Diseases
Current Medicinal Chemistry PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Potential and Cytotoxicity of cis-Platinum Complex with Anti-tumor Activity in Combination Therapy
Recent Patents on Anti-Cancer Drug Discovery Recent Developments in Nano-Drug Delivery Systems Loaded by Phytochemicals for Wound Healing
Mini-Reviews in Medicinal Chemistry